Article

Upcoming lung cancer webinar

Author(s):

I just got an alert that the Lung Cancer Alliance and Legacy will be holding a panel to discuss the impact of lung cancer.The moderated panel, which will feature several experts, will specifically discuss the impact on certain groups, including men, women, minorities and veterans. Other issues that will be discussed include challenges and opportunities in public health strategies about reducing lung cancer deaths.The panel will be held February 2 from 9 a.m. to 11 a.m. in Washington, D.C. To find out more information, visit The Lung Cancer Alliance.Also, you can watch the webinar online at www.lungcanceralliance.org. (The link will go live 10 minutes before the start of the program.) If you aren't able to watch on February 2, don't worry. The webinar will be available online for the month of February.To learn more about the progress being made in treating lung cancer, check out Lung Overdue.

Related Videos
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
1 expert is featured in this series.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Related Content